Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 5
2009 14
2010 37
2011 51
2012 58
2013 70
2014 79
2015 99
2016 79
2017 86
2018 80
2019 48
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

609 results
Results by year
Filters applied: . Clear all
Page 1
Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets
Klingenberg M, et al. J Hepatol 2017 - Review. PMID 28438689
The majority of the human genome is not translated into proteins but can be transcribed into RNA. Even though the resulting non-coding RNAs (ncRNAs) do not encode for proteins, they contribute to diseases such as cancer. ...
The majority of the human genome is not translated into proteins but can be transcribed into RNA. Even though the resulting non-codin …
Drug-induced liver injury: recent advances in diagnosis and risk assessment
Kullak-Ublick GA, et al. Gut 2017 - Review. PMID 28341748 Free PMC article.
Genetic risk assessment is useful mainly due to its high negative predictive value, with several human leucocyte antigen alleles being associated with DILI. New emerging biomarkers which could be useful in assessing DILI include total keratin18 (K18) and caspase-cleaved keratin18 (ccK18), macrophage colony-stimulating factor receptor 1, high mobility group box 1 and microRNA-122. ...
Genetic risk assessment is useful mainly due to its high negative predictive value, with several human leucocyte antigen alleles bein …
Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis
Fong MY, et al. Nat Cell Biol 2015. PMID 25621950 Free PMC article.
Here we show that cancer cells can suppress glucose uptake by non-tumour cells in the premetastatic niche, by secreting vesicles that carry high levels of the miR-122 microRNA. ...
Here we show that cancer cells can suppress glucose uptake by non-tumour cells in the premetastatic niche, by secreting vesicles that carry …
miR-122--a key factor and therapeutic target in liver disease
Bandiera S, et al. J Hepatol 2015 - Review. PMID 25308172 Free article.
Being the largest internal organ of the human body with the unique ability of self-regeneration, the liver is involved in a wide variety of vital functions that require highly orchestrated and controlled biochemical processes. ...
Being the largest internal organ of the human body with the unique ability of self-regeneration, the liver is involved in a wide vari …
LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation
Cheng D, et al. EBioMedicine 2018. PMID 30195653 Free PMC article.
BACKGROUND: MicroRNA-122 (miR-122), a pivotal liver-specific miRNA, is frequently repressed in hepatocellular carcinoma (HCC) and associated with poor prognosis. ...
BACKGROUND: MicroRNA-122 (miR-122), a pivotal liver-specific miRNA, is frequently repressed in hepatocellular carcinoma (HCC) and ass …
609 results
Jump to page
Feedback